Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases.

[1]  D. Scharnweber,et al.  Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues. , 2013, Current medicinal chemistry.

[2]  M. Soma,et al.  Complement‐mediated chronic inflammation is associated with diabetic microvascular complication , 2013, Diabetes/metabolism research and reviews.

[3]  S. Ikegawa,et al.  Human Genetic Disorders Caused by Mutations in Genes Encoding Biosynthetic Enzymes for Sulfated Glycosaminoglycans* , 2013, The Journal of Biological Chemistry.

[4]  Jun Liu,et al.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. , 2013, Arthritis and rheumatism.

[5]  E. Puffenberger,et al.  Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup , 2013, Proceedings of the National Academy of Sciences.

[6]  A. Nesburn,et al.  Mitochondrial DNA Variants Mediate Energy Production and Expression Levels for CFH, C3 and EFEMP1 Genes: Implications for Age-Related Macular Degeneration , 2013, PloS one.

[7]  K. Wiley,et al.  Ethnic Differences in DNA Methyltransferases Expression in Patients with Systemic Lupus Erythematosus , 2012, Journal of Clinical Immunology.

[8]  M. Marazita,et al.  Interaction between IRF6 and TGFA Genes Contribute to the Risk of Nonsyndromic Cleft Lip/Palate , 2012, PloS one.

[9]  M. Tuszynski,et al.  JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides , 2012, Neuron.

[10]  G. Alarcón,et al.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. , 2012, Arthritis and rheumatism.

[11]  E. Ruiz-Pesini,et al.  Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. , 2012, Biochimica et biophysica acta.

[12]  F. Liew,et al.  Interleukin-33 and the function of innate lymphoid cells. , 2012, Trends in immunology.

[13]  T. Laveist,et al.  Racial/Ethnic Disparities in the Prevalence of Selected Chronic Diseases Among US Air Force Members, 2008 , 2012, Preventing chronic disease.

[14]  S. John,et al.  JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death , 2012, Neurobiology of Disease.

[15]  Hsiao-Wen Chen,et al.  A mitochondrial etiology of Alzheimer and Parkinson disease. , 2012, Biochimica et biophysica acta.

[16]  F. Liew,et al.  IL-33: a Janus cytokine , 2012, Annals of the rheumatic diseases.

[17]  N. Oreiro,et al.  Mitochondrial Haplogroups Define Two Phenotypes of Osteoarthritis , 2012, Front. Physio..

[18]  N. Arsenijević,et al.  IL-33/ST2 axis in inflammation and immunopathology , 2012, Immunologic research.

[19]  V. Yong,et al.  Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system. , 2011, Autoimmunity reviews.

[20]  M. Schmitz,et al.  The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB–Stimulated Gene Transcription , 2011, The Journal of Immunology.

[21]  K. Ohno-Matsui.  Parallel findings in age-related macular degeneration and Alzheimer’s disease , 2011, Progress in Retinal and Eye Research.

[22]  R. Testa,et al.  Mitochondrial DNA Backgrounds Might Modulate Diabetes Complications Rather than T2DM as a Whole , 2011, PloS one.

[23]  Wei Zhang,et al.  Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens. , 2011, The American journal of pathology.

[24]  A. Czarnecka,et al.  The Role of the Mitochondrial Genome in Ageing and Carcinogenesis , 2011, Journal of aging research.

[25]  M. Hauptmann,et al.  Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as Serum Biomarkers for Response to Epidermal Growth Factor Receptor Inhibitors in Patients with Advanced Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  Manuela G. López,et al.  Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans. , 2010, Osteoarthritis and cartilage.

[27]  P. du Souich,et al.  Modulation of inflammation by chondroitin sulfate. , 2010, Osteoarthritis and cartilage.

[28]  C. Januário,et al.  Mitochondrial-dependent apoptosis in Huntington's disease human cybrids , 2010, Experimental Neurology.

[29]  R. Gold,et al.  Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease , 2010, Journal of Molecular Medicine.

[30]  B. Vainer,et al.  IL-33 is upregulated in colonocytes of ulcerative colitis. , 2010, Immunology letters.

[31]  I. McInnes,et al.  Role of interleukin 33 in human immunopathology , 2009, Annals of the rheumatic diseases.

[32]  I. McInnes,et al.  IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation1 , 2009, The Journal of Immunology.

[33]  K. Langa,et al.  Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites , 2009, Alzheimer's & Dementia.

[34]  J. Moreno-Navarrete,et al.  Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance , 2009, Diabetes.

[35]  L. Rönnblom,et al.  C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. , 2009, Arthritis and rheumatism.

[36]  J. Beckmann,et al.  JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis , 2009, Diabetologia.

[37]  P. du Souich,et al.  Immunomodulatory and anti-inflammatory effects of chondroitin sulphate , 2009, Journal of cellular and molecular medicine.

[38]  J. Langberg,et al.  Mitochondrial DNA haplogroups associated with age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[39]  H. Kita,et al.  IL-33-activated dendritic cells induce an atypical TH2-type response. , 2009, The Journal of allergy and clinical immunology.

[40]  D. Taverna,et al.  Mitochondrial DNA variability modulates mRNA and intra-mitochondrial protein levels of HSP60 and HSP75: experimental evidence from cybrid lines , 2009, Cell Stress and Chaperones.

[41]  D. Turnbull,et al.  Batteries not included: diagnosis and management of mitochondrial disease , 2009, Journal of internal medicine.

[42]  J. Pollheimer,et al.  Vascular Biology , Atherosclerosis and Endothelium Biology Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation , 2010 .

[43]  Dirk E. Smith,et al.  IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. , 2008, International immunology.

[44]  S. Campo,et al.  Purified human plasma glycosaminoglycans reduced NF-κB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes , 2008, Innate immunity.

[45]  J. Manly,et al.  Diagnosis and assessment of Alzheimer's disease in diverse populations , 2008, Alzheimer's & Dementia.

[46]  Ashley M. Miller,et al.  IL-33 reduces the development of atherosclerosis , 2008, The Journal of experimental medicine.

[47]  I. McInnes,et al.  IL‐33 is a chemoattractant for human Th2 cells , 2007, European journal of immunology.

[48]  M. Peek,et al.  Diabetes Health Disparities , 2007, Medical care research and review : MCRR.

[49]  Patrick F Chinnery,et al.  Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. , 2007, American journal of human genetics.

[50]  Delphine A. Lacorre,et al.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.

[51]  C. Franceschi,et al.  Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[52]  A. R. Vieira,et al.  Human Genome Epidemiology (HuGE) Review Association between the Transforming Growth Factor Alpha Gene and Nonsyndromic Oral Clefts: A HuGE Review , 2006 .

[53]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[54]  V. Álvarez,et al.  Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population , 2005, Journal of the Neurological Sciences.

[55]  S. Jazwinski,et al.  Nuclear gene expression changes due to mitochondrial dysfunction in ARPE-19 cells: implications for age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.

[56]  Ali H. Mokdad,et al.  State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.

[57]  M. Fennell,et al.  Targeting JNK3 for the treatment of neurodegenerative disorders. , 2004, Drug discovery today.

[58]  J. Gilbert,et al.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk , 2004, Neuroscience Letters.

[59]  I. McInnes,et al.  A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST21 , 2004, The Journal of Immunology.

[60]  R. Scott,et al.  Mitochondrial DNA lineages of elite Ethiopian athletes. , 2004, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[61]  J. Haines,et al.  Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. , 2003, American journal of human genetics.

[62]  C. Weitz,et al.  Regulation of Daily Locomotor Activity and Sleep by Hypothalamic EGF Receptor Signaling , 2001, Science.

[63]  M. Walport,et al.  Pathogenesis of systemic lupus erythematosus (SLE) , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[64]  M. Formato,et al.  Urinary glycosaminoglycans in patients with systemic lupus erythematosus. , 2001, Clinical and experimental rheumatology.

[65]  D. Wallace,et al.  Functional Analysis of Lymphoblast and Cybrid Mitochondria Containing the 3460, 11778, or 14484 Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutation* , 2000, The Journal of Biological Chemistry.

[66]  J. Montoya,et al.  [Diseases of mitochondrial DNA]. , 2000, Revista de neurologia.

[67]  N. Inoue,et al.  Selective complement C1s deficiency caused by homozygous four-base deletion in the C1s gene , 1998, Human Genetics.

[68]  G. Kahaly,et al.  Glycosaminoglycans in autoimmunity. , 1996, Clinical and experimental rheumatology.

[69]  D. Wallace,et al.  Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia , 1996, Molecular and cellular biology.

[70]  D. Wallace.  Mitochondrial DNA mutations in diseases of energy metabolism , 1994, Journal of bioenergetics and biomembranes.

[71]  C. Cepko,et al.  Control of proliferation in the retina: temporal changes in responsiveness to FGF and TGF alpha. , 1992, Development.

[72]  F. Sharp,et al.  Epidermal growth factor and transforming growth factor α induce c‐fos gene expression in retinal muller cells in vivo , 1991, Journal of neuroscience research.

[73]  G. Schultz,et al.  Transforming growth factor alpha and its receptor in neural retina. , 1989, Investigative ophthalmology & visual science.

[74]  L. Nanney,et al.  Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. , 1987, The New England journal of medicine.

[75]  R. Derynck,et al.  Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation. , 1985, Cancer research.

[76]  Lijuan Zhang,et al.  Activated contact system and abnormal glycosaminoglycans in lupus and other auto- and non-autoimmune diseases. , 2010, Progress in molecular biology and translational science.

[77]  P. Souich,et al.  Modulation of in fl ammation by chondroitin sulfate , 2010 .

[78]  R. Scott,et al.  Mitochondrial haplogroups associated with elite Kenyan athlete status. , 2009, Medicine and science in sports and exercise.

[79]  K. Cardarelli,et al.  Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. , 2007, Ethnicity & disease.

[80]  N. Anderson,et al.  Ethnic Differences in Dementia and Alzheimer's Disease , 2004 .

[81]  A. Chomyn.  Platelet-mediated transformation of human mitochondrial DNA-less cells. , 1996, Methods in Enzymology.